ASX:SOM (Australia)  
SomnoMed Ltd logo

SomnoMed Ltd

A$ 1.47 (+5%) Sep 30
On watch
P/E:
At Loss
P/B:
4.15
Market Cap:
A$ 115.48M ($ 74.48M)
Enterprise V:
A$ 111.85M ($ 72.14M)
Volume:
260.00
Avg Vol (2M):
58.11K
Also Trade In:
Volume:
260.00
Market Cap A$:
115.48M
Market Cap $:
74.48M
PE Ratio:
At Loss
Avg Vol (2-Month):
58.11K
Enterprise Value A$:
111.85M
Enterprise Value $:
72.14M
PB Ratio:
4.15
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard, which protects patients from teeth grinding damage, as well as SomTabs for cleaning its devices. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.
Name Current Vs Industry Vs History
Cash-To-Debt 1.3
Equity-to-Asset 0.48
Debt-to-Equity 0.43
Debt-to-EBITDA 22.88
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.17
Distress
Grey
Safe
Beneish M-Score -2.87
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 71.79
9-Day RSI 68.08
14-Day RSI 65.54
6-1 Month Momentum % -32.99
12-1 Month Momentum % -44.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.28
Quick Ratio 1.15
Cash Ratio 0.66
Days Inventory 34.56
Days Sales Outstanding 41.68
Days Payable 151.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.1

Financials

ASX:SOM's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 72.58
EPS (TTM) (A$) -0.057
Beta 1.78
Volatility % 43.22
14-Day RSI 65.54
14-Day ATR (A$) 0.047166
20-Day SMA (A$) 1.333
12-1 Month Momentum % -44.68
52-Week Range (A$) 1.115 - 2.65
Shares Outstanding (Mil) 78.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

SomnoMed Ltd Filings

Document Form Filing Date
No Filing Data

SomnoMed Ltd Analysis

Share your research